Based on recent research that the CXCL12–CXCR4/CXCR7 axis is involved in survival, tumor growth, angiogenesis, metastasis, TME, and drug resistance, it is considered a promising target for therapeutic intervention. Here, ACKR3 is linked to neoplasm.